Triple IPA
Selected indexed studies
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. (Nat Genet, 2020) [PMID:32424353]
- DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy. (Int J Cancer, 2023) [PMID:36305646]
- Gut microbiota and gut-derived metabolites are altered and associated with dietary intake in women with polycystic ovary syndrome. (J Ovarian Res, 2024) [PMID:39578890]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. (2020) pubmed
- DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy. (2023) pubmed
- Gut microbiota and gut-derived metabolites are altered and associated with dietary intake in women with polycystic ovary syndrome. (2024) pubmed
- The role of collagen triple helix repeat containing 1 (CTHRC1) in cancer development and progression. (2024) pubmed
- MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome. (2024) pubmed
- Transcriptome Analysis of Triple-Negative HCC1937 and MDA-MB-231 Breast Cancer Cells Treated with Kalanchoe pinnata Revealed the Regulation of Migration and Invasion via the Downregulation of the Genes JAK2, ROCK1 and ROCK2. (2025) pubmed
- Combining Sorafenib, Se-methylselenocysteine, and α-Ketoacid for synergistic cytotoxicity in Hepatocellular carcinoma cell lines. (2025) pubmed
- MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway. (2020) pubmed
- Disrupted Lipid Metabolism, Cytokine Signaling, and Dormancy: Hallmarks of Doxorubicin-Resistant Triple-Negative Breast Cancer Models. (2024) pubmed
- Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients. (2021) pubmed